<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.1d3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">83712</article-id><article-id pub-id-type="doi">10.7554/eLife.83712</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Cancer Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Cell Biology</subject></subj-group></article-categories><title-group><article-title>CYRI-B mediated macropinocytosis drives metastasis via lysophosphatidic acid receptor uptake</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-357134"><name><surname>Nikolaou</surname><given-names>Savvas</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-296277"><name><surname>Juin</surname><given-names>Amelie</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-2"/><xref ref-type="other" rid="par-3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-296278"><name><surname>Whitelaw</surname><given-names>Jamie A</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-6739-1032</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-2"/><xref ref-type="other" rid="par-3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-296279"><name><surname>Paul</surname><given-names>Nikki R</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-2"/><xref ref-type="other" rid="par-3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-284576"><name><surname>Fort</surname><given-names>Loic</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-6939-3621</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="par-2"/><xref ref-type="other" rid="par-3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-296280"><name><surname>Nixon</surname><given-names>Colin</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-8085-2160</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-2"/><xref ref-type="other" rid="par-3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-296281"><name><surname>Spence</surname><given-names>Heather J</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-2"/><xref ref-type="other" rid="par-3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-234430"><name><surname>Bryson</surname><given-names>Sheila</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-2"/><xref ref-type="other" rid="par-3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-356765"><name><surname>Machesky</surname><given-names>Laura M</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-7592-9856</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="other" rid="par-3"/><xref ref-type="other" rid="par-4"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution>Cancer Research UK Beatson Institute</institution>, <addr-line><named-content content-type="city">Glasgow</named-content></addr-line>, <country>United Kingdom</country></aff><aff id="aff2"><institution content-type="dept">Department of Cell and Developmental Biology</institution>, <institution>Vanderbilt University</institution>, <addr-line><named-content content-type="city">Nashville</named-content></addr-line>, <country>United States</country></aff><aff id="aff3"><institution content-type="dept">Department of Biochemistry</institution>, <institution>University of Cambridge</institution>, <addr-line><named-content content-type="city">Cambridge</named-content></addr-line>, <country>United Kingdom</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-13853"><name><surname>Golemis</surname><given-names>Erica A</given-names></name><role>Reviewing editor</role><aff><institution>Fox Chase Cancer Center</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>lmm202@cam.ac.uk</email> (LM);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>07</day><month>05</month><year>2024</year></pub-date><volume>13</volume><elocation-id>e83712</elocation-id><history><date date-type="received"><day>26</day><month>09</month><year>2022</year></date><date date-type="accepted"><day>06</day><month>05</month><year>2024</year></date></history><permissions><copyright-statement>Â© 2024, Nikolaou et al</copyright-statement><copyright-year>2024</copyright-year><copyright-holder>Nikolaou et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-83712-v1.pdf"/><abstract><p>Pancreatic ductal adenocarcinoma carries a dismal prognosis, with high rates of metastasis and few treatment options. Hyperactivation of KRAS in almost all tumours drives RAC1 activation, conferring enhanced migratory and proliferative capacity as well as macropinocytosis. Macropinocytosis is well understood as a nutrient scavenging mechanism, but little is known about its functions in trafficking of signaling receptors. We find that CYRI-B is highly expressed in pancreatic tumours in a mouse model of KRAS and p53-driven pancreatic cancer. Deletion of <italic>Cyrib</italic> (the gene encoding CYRI-B protein) accelerates tumourigenesis, leading to enhanced ERK and JNK-induced proliferation in precancerous lesions, indicating a potential role as a buffer of RAC1 hyperactivation in early stages. However, as disease progresses, loss of CYRI-B inhibits metastasis. CYRI-B depleted tumour cells show reduced chemotactic responses to lysophosphatidic acid, a major driver of tumour spread, due to impaired macropinocytic uptake of the lysophosphatidic acid receptor-1. Overall, we implicate CYRI-B as a mediator of growth and signaling in pancreatic cancer, providing new insights into pathways controlling metastasis.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000289</institution-id><institution>Cancer Research UK</institution></institution-wrap></funding-source><award-id>A24452</award-id><principal-award-recipient><name><surname>Machesky</surname><given-names>Laura M</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000289</institution-id><institution>Cancer Research UK</institution></institution-wrap></funding-source><award-id>A17196</award-id><principal-award-recipient><name><surname>Juin</surname><given-names>Amelie</given-names></name><name><surname>Whitelaw</surname><given-names>Jamie A</given-names></name><name><surname>Paul</surname><given-names>Nikki R</given-names></name><name><surname>Fort</surname><given-names>Loic</given-names></name><name><surname>Nixon</surname><given-names>Colin</given-names></name><name><surname>Spence</surname><given-names>Heather J</given-names></name><name><surname>Bryson</surname><given-names>Sheila</given-names></name><name><surname>Machesky</surname><given-names>Laura M</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000289</institution-id><institution>Cancer Research UK</institution></institution-wrap></funding-source><award-id>A31287</award-id><principal-award-recipient><name><surname>Juin</surname><given-names>Amelie</given-names></name><name><surname>Whitelaw</surname><given-names>Jamie A</given-names></name><name><surname>Paul</surname><given-names>Nikki R</given-names></name><name><surname>Fort</surname><given-names>Loic</given-names></name><name><surname>Nixon</surname><given-names>Colin</given-names></name><name><surname>Spence</surname><given-names>Heather J</given-names></name><name><surname>Bryson</surname><given-names>Sheila</given-names></name><name><surname>Machesky</surname><given-names>Laura M</given-names></name></principal-award-recipient></award-group><award-group id="par-4"><funding-source><institution-wrap><institution>EPSRC UKRI</institution></institution-wrap></funding-source><award-id>EP/T00213/1</award-id><principal-award-recipient><name><surname>Machesky</surname><given-names>Laura M</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: Mice were maintained by the Biological Services Unit staff according to the UK home office regulations and instructions. The experiments were approved by the local Animal Welfare and Ethical Review Body (AWERB) of the University of Glasgow and performed under UK Home office licence PE494BE48 to LMM.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>All Western blot and numerical data generated or analysed during this study are included in the manuscript and supporting files; source data files have been provided for all graphs and western blots.</p></sec><supplementary-material><ext-link xlink:href="elife-83712-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>